Crossmark

Can the detection of serum glutathione reductase serve as an effective complement to traditional tumor biomarkers in clinical laboratory medicine for patients with hepatocellular carcinoma?

Crossref DOI link: https://doi.org/10.1186/s12885-025-15383-3

Published Online: 2025-11-26

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Zheng, Qingzhu

Chen, Siyan

Weng, Jiamiao

Huang, Huaxiang

Xu, Xiaohong

Cao, Yingping
Funding

Funding for this research was provided by:

Fujian Provincial Natural Science Foundation of China (2024J01585)

BS-1000M Fully Automated Biochemical Analyzer Performance Evaluation and Special Sample Type Applicability Research Project (320.6750.2025-5-54)

First Phase of the Sixth Batch of Cultivation Discipline Construction Projects (2025PYXKC11)
License Information

Text and Data Mining valid from 2025-11-26

Version of Record valid from 2025-12-30
More Information

Article History

Received: 23 October 2024

Accepted: 23 November 2025

First Online: 26 November 2025

Declarations

:

: The study was approved by the Institutional Review Board of Fujian Medical University Union Hospital. (Ethics No.: 2023KJCX052).

: All the authors agree to the content of the paper.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below